Industry reports
Editor highlights

Dendreon Market and Forecasts, April 2014

You might be interested in: cell therapy, ovarian cancer, clinical trial, more »


 

» View Public Reports

1-10 of 13 reports for Dendreon

Vaccine Business Brief

  • Industry report
  • January 2013
  • 2 pages

... Opportunities for new players entering this market. The launch of the first fda-approved therapeutic vaccine, provenge by dendreon (u.S.), For treating prostate cancer has acknowledged the potential ...

Cell Therapy in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • October 2013
  • 28 pages

... Manufactu scale, fit with legacy industry reneuron, athersys autologous service first mover, cost, entry barriers dendreon, cell medica autolagous equipment consumables, cytori sales first mover ...

The Future of Biological Therapy

  • Industry report
  • April 2012
  • 20 pages

... Sante /none biovex/amgen express target proteins inconsistent dosing consistent dosing dendritic cells: dendreon - market argos product on the market complex ...

Pharmaceutical Sector Brief

  • Industry report
  • January 2012
  • 5 pages

... Neca novartis Lgene r Ectrum Arma Ntocor Totec Attle Netics Nssen dendreon No Rc Sai Los Exion Armaceuticals r Alt Are Rdue 2 *2011 ...

Pharmaceutical Business in Australia and The United States

  • Industry report
  • October 2012
  • 32 pages

... Safety andtoxicity profile research into cancer immunotherapy has led to recentregulatory approval success: dendreon s provenge approval in 2010 (fda) bristol-myers squibb syervoy approval in 2012 ...

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • July 2012
  • 43 pages
  • by Corporation

... Into commercial and medical affairs 33 amgen amylin bristol-myers squibb daiichi-sankyo dendreon elan gilead glaxosmithkline ipsen johnson & johnson lilly merck novartis novo nordisk roche ...

World Laboratory Equipment : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 6 pages

... Science, biogen idec, boehringer- ingelheim, bristol myers squibb, csl ltd, daiichi-sankyo, dendreon, eisai, eli lilly & co, gilead sciences, glaxosmithkline, johnson & johnson, merck & co, merck serono ...

Prostate Cancer Market Analysis in Jordan

  • Industry report
  • September 2012
  • 88 pages

... Resistant prostate cancer Docetaxel (sanofi-aventis)(2004) Sipuleucel-t (dendreon)(2010) Cabazitaxel (sanofi-aventis)(2010) Abiraterone (janssen biotech) (2011) Enzalutamide (medivation)(2012) Zoledronic ...

Cell Therapy in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 26 pages

... Healing) dermagraft skin altrika myskin skin avita medical recell skin biotissue technologies gmbh bioseed-c cartilage dendreon provenge cancer euroderm epidex, epigraft skin japan tissue engineering co. J ...

Cell Therapy Market Overview

  • Industry report
  • September 2013
  • 28 pages

... Cornea autologous dendritic cells - immunotherapy provenge (sipuleucel-t; dendreon) asymptomatic metastatic hormone refractory prostate cancer phase 1 register 2 3 launch late stage regenerative medicine ...

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.